RR Donnelley to Pursue New Blockchain-Enabled Capabilities for Publishing Industry
Mar 14, 2016 10:30 am UTC| Business
CHICAGO, March 14, 2016 -- R. R. Donnelley Sons Company (Nasdaq:RRD) announced today that it is teaming with Context Labs (CXL) to pursue leading-edge, blockchain-enabled technology for its global publishing customers....
Vical Reports Fourth Quarter 2015 Financial Results
Mar 14, 2016 10:30 am UTC| Business
Futility Analyses Completed on CMV Phase 3 Trial in HCT Patients and Trial Continuing as Planned Phase 1 Trial Initiated for Novel Antifungal SAN DIEGO, March 14, 2016 -- Vical Incorporated (Nasdaq:VICL) today...
Mar 14, 2016 10:05 am UTC| Business
Deerfield Beach, FL, March 14, 2016 -- Zion Research has published a new report titled “Natural Refrigerants (Ammonia, Hydrocarbons, Carbon dioxide and Others) Market for Commercial, Industrial, Domestic, Stationary Air...
RadNet Reports Fourth Quarter and Full Year 2015 Results and Releases 2016 Financial Guidance
Mar 14, 2016 10:00 am UTC| Business
For the fourth quarter, RadNet reports Total Net Revenue (“Revenue”) of $215.7 million and Adjusted EBITDA(1)of $32.6 million, increases of 16.3% and 1.9%, respectively, over the prior year’s fourth quarterIntegration...
MotionDSP and Ascent Vision Announce Joint Innovative Aerial Intelligence Solution
Mar 14, 2016 10:00 am UTC| Business
Burlingame, March 14, 2016 -- MotionDSP, a leading provider of image processing and computer vision software today announced a partnership with Ascent Vision Technologies, a manufacturer and distributor of best-in-class...
Whitestone REIT’s Board of Trustees Declares Second Quarter 2016 Dividend
Mar 14, 2016 10:00 am UTC| Business
HOUSTON, March 14, 2016 -- Whitestone REIT (NYSE:WSR) (“Whitestone” or the “Company”) announced today that its Board of Trustees has declared a quarterly cash dividend for the 2016 second quarter of 28.5 cents per share...
Mar 14, 2016 10:00 am UTC| Business
AMSTERDAM, the Netherlands, March 14, 2016 -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that the Company has treated the first patient in the second cohort of its ongoing AMT-060-01 Phase...